To investigate this process in vivo, we used a described previously mouse lung cancer model of Hace1 inactivation in which deletion of Rac1 and expression of oncogenic KRasG12D can be simultaneously induced by Adeno-Cre administration [3, 53]. The gene discussed is RAC1; the disease is lung carcinoma.